Onyx Bridge Wealth Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Sell
1,929
-6
-0.3% -$2.05K 0.06% 194
2026
Q1
$681K Buy
1,935
+60
+3% +$21.4K 0.07% 180
2025
Q4
$614K Buy
1,875
+95
+5% +$30.1K 0.07% 195
2025
Q3
$502K Buy
1,780
+242
+16% +$70.2K 0.05% 216
2025
Q2
$429K Buy
1,538
+108
+8% +$30.6K 0.06% 186
2025
Q1
$446K Buy
1,430
+8
+0.6% +$2.36K 0.06% 170
2024
Q4
$371K Buy
1,422
+57
+4% +$16.9K 0.05% 186
2024
Q3
$440K Buy
1,365
+10
+0.7% +$3.27K 0.07% 173
2024
Q2
$423K Sell
1,355
-25
-2% -$7.34K 0.07% 164
2024
Q1
$373K Buy
1,380
+17
+1% +$4.97K 0.07% 172
2023
Q4
$393K Buy
+1,363
New +$371K 0.08% 155

Other funds holding AMGN

Onyx Bridge Wealth Group's AMGN Position: Q2 2026 in Review

Onyx Bridge Wealth Group reduced its Amgen (AMGN) stake by 0.31% in Q2 2026, selling an estimated $2.05K and leaving 1,929 shares worth $699K. The position accounts for 0.06% of the portfolio, ranked #194.

Onyx Bridge Wealth Group first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Onyx Bridge Wealth Group held 1,929 shares of Amgen worth $699K as of Q2 2026.
  • Onyx Bridge Wealth Group sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.06% of Onyx Bridge Wealth Group's portfolio in Q2 2026, its #194 holding.
  • Onyx Bridge Wealth Group first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Onyx Bridge Wealth Group's 13F filing for Q2 2026, filed 23 Jul 2026.